3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Lymphoid
1
Breast
1
Conditions
Breast Neoplasms
6
Lung Neoplasms
5
Colorectal Neoplasms
5
Prostatic Neoplasms
3
Motor Activity
3
Hodgkin Disease
2
Hematopoietic and Lymphoid System Neoplasm
2
Carcinoma, Non-Small-Cell Lung
2
Urinary Bladder Neoplasms
1
Stress Disorders, Post-Traumatic
1
Sleep Wake Disorders
1
Sedentary Behavior
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Polycystic Ovary Syndrome
1
Pathologically Proven Gastrointestinal Malignancy
1
Obesity
1
Neoplasms
1
Neoplasm Metastasis
1
Multiple Myeloma
1
Melanoma
1
Lymphoma, Non-Hodgkin
1
Lymphoma, Follicular
1
Leukemia, Lymphocytic, Chronic, B-Cell
1
Insulin Resistance
1
Inflammatory Breast Neoplasms
1
Hematopoietic and Lymphatic System Neoplasm
1
Head and Neck Neoplasms
1
Fatigue
1
FIGO Grade 1 Endometrial Endometrioid Adenocarcinoma
1
Depression
1
Interventions
Cyclophosphamide
21
Cyclosporine
14
fludarabine phosphate
13
Whole-Body Irradiation
13
Peripheral Blood Stem Cell Transplantation
13
Filgrastim
10
Rituximab
9
Mycophenolic Acid
9
Antilymphocyte Serum
9
Radiotherapy
7
Methotrexate
7
Busulfan
7
Melphalan
6
Psychiatric Rehabilitation
5
Etoposide
5
Dexamethasone
5
Cytarabine
5
Aprepitant
5
fludarabine
4
Vincristine
4
Ondansetron
4
Methylprednisolone
4
Granulocyte Colony-Stimulating Factor
4
Doxorubicin
4
Cord Blood Stem Cell Transplantation
4
plerixafor
3
Zidovudine
3
Therapeutics
3
Stem Cell Transplantation
3
Prednisone
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase NA
×
Lymphoma, Non-Hodgkin
×
Exercise Test
×
Clear all
NCT05595577
2026-03-20
PALS
Wake Forest University Health Sciences
Phase NA
Recruiting
110 enrolled